Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.

Mahmood D, Grubbström M, Lundberg LD, Olivecrona G, Olivecrona T, Stegmayr BG.

BMC Nephrol. 2010 Dec 6;11:33. doi: 10.1186/1471-2369-11-33.

2.

Lipoprotein lipase activity is favoured by peritoneal dialysis compared to hemodialysis.

Mahmood D, Nilsson S, Olivecrona G, Stegmayr B.

Scand J Clin Lab Invest. 2014 Jun;74(4):296-300. doi: 10.3109/00365513.2014.882016. Epub 2014 Feb 24.

PMID:
24564630
4.

Lipoprotein lipase during heparin infusion: lower activity in hemodialysis patients.

Näsström B, Olivecrona G, Olivecrona T, Stegmayr BG.

Scand J Clin Lab Invest. 2003;63(1):45-53.

PMID:
12729069
5.

Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.

Lord H, Jean N, Dumont M, Kassis J, Leblanc M.

Am J Nephrol. 2002 Jan-Feb;22(1):58-66.

PMID:
11919404
6.

A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.

Näsström B, Stegmayr B, Gupta J, Olivecrona G, Olivecrona T.

Nephrol Dial Transplant. 2005 Jun;20(6):1172-9. Epub 2005 Mar 29.

PMID:
15797889
7.

Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.

Al-Saran KA, Sabry A, Taha M, Ghafour MA, Al Fawzan F.

Saudi J Kidney Dis Transpl. 2010 Jan;21(1):43-9.

9.

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.

Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F.

Kidney Int. 1988 Apr;33(4):890-6.

10.

Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial.

Rodger MA, Ramsay T, MacKinnon M, Westphal M, Wells PS, McCormick B, Knoll G.

Am J Kidney Dis. 2012 Sep;60(3):427-34. doi: 10.1053/j.ajkd.2012.01.020. Epub 2012 Apr 4.

PMID:
22480794
11.

Response of angiopoietin-like proteins 3 and 4 to hemodialysis.

Mahmood D, Makoveichuk E, Nilsson S, Olivecrona G, Stegmayr B.

Int J Artif Organs. 2014 Jan;37(1):13-20. doi: 10.5301/ijao.5000252. Epub 2014 Jan 16.

PMID:
24634330
12.

Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted.

Näsström B, Olivecrona G, Olivecrona T, Stegmayr BG.

J Lab Clin Med. 2001 Sep;138(3):206-13.

PMID:
11528374
13.

Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.

Goto T, Saika H, Takahashi T, Maeda A, Mune M, Yukawa S.

Kidney Int Suppl. 1999 Jul;71:S213-5.

PMID:
10412779
14.

Comparison of two low-molecular weight heparins (LMWHs), tinzaparin and bemiparin, during hemodialysis.

Christidou FN, Frangia TK, Bamichas GI, Gionanlis LC, Natse TA, Georgoulis IE, Sombolos KI.

Int J Clin Pharmacol Ther. 2005 Jul;43(7):335-8.

PMID:
16035376
15.

Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.

Sabry A, Taha M, Nada M, Al Fawzan F, Alsaran K.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):57-62. doi: 10.1097/MBC.0b013e32831bec0f.

PMID:
20523166
16.

Effect of switching unfractionated heparin to low-molecular-weight heparin on serum potassium in hemodialysis patients.

Ezzatzadegan Jahromi S, Mahmoodi MS, Behroozi F, Roozbeh J, Emamghoreishi F.

Iran J Kidney Dis. 2014 Nov;8(6):475-80.

17.

Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.

Hainer JW, Sherrard DJ, Swan SK, Barrett JS, Assaid CA, Fossler MJ, Cox DS, Williams RM, Pittenger AL, Stephenson CA, Hua TA.

Am J Kidney Dis. 2002 Sep;40(3):531-8.

PMID:
12200805
18.

Use of low-dose low molecular weight heparin in hemodialysis.

Lai KN, Wang AY, Ho K, Szeto CC, Li M, Wong LK, Yu AW.

Am J Kidney Dis. 1996 Nov;28(5):721-6.

PMID:
9158210
19.

[Use of low molecular-weight heparin in hemodialysis patients].

Schrader J, Rieger J, Müschen H, Stibbe W, Köstering H, Kramer P, Scheler F.

Klin Wochenschr. 1985 Jan 15;63(2):49-55. German.

PMID:
3981950

Supplemental Content

Support Center